Skip to main content
Premium Trial:

Request an Annual Quote

Rheonix Gets FDA Emergency Use Authorization for Coronavirus MDx Test

NEW YORK – Rheonix said on Thursday that it has received Emergency Use Authorization from the US Food and Drug Administration for the Rheonix COVID-19 MDx assay.

The endpoint RT-PCR test is processed on the company's Encompass CARD cartridge, which runs on Rheonix's Encompass MDx workstation. It is intended for the qualitative detection of nucleic acid from SARS-CoV-2 in respiratory samples from individuals suspected by their healthcare provider of having COVID-19.

Rheonix said that the assay is fully automated and can provide same-day results for low- and medium-throughput laboratories. The company said that it has begun shipping the workstation and test kits to high-need local and regional hospital laboratories to enable them to begin testing immediately.

Ithaca, NY-based Rheonix is currently seeking full FDA clearance for the Encompass workstation and a triplex sexually transmitted infection assay to simultaneously detect nucleic acid from Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis from patient samples.

The Scan

UK Moves to Allow Sale of Gene-Edited Food

The UK is moving ahead to allow the sale of gene-edited food in England, Scotland, and Wales, according to New Scientist.

Questions for the Field

Stat News writes that the alleged Buffalo shooter's citation of genetics research raises questions about what the field can do.

Cell Studies on Tumor Evolution in Mouse Model of Lung Cancer, Stereo-seq, Bacteriophage Responses

In Cell this week: tumor evolution tracked in mouse model of lung cancer, organogenesis mapped using Stereo-seq, and more.

Taking Stock of the Stockpile

The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.